Pharma companies have begun proposing to the Health Ministry several alternatives to raising med prices that would help manufacturers reduce their losses, chairman of the Federation of Egyptian Industries’ pharma division Ahmed El Ezaby tells Al Mal. The proposals include only raising prices on meds that were not affected by the last price hikes in January, while keeping the price of other meds stable. This would not affect diabetes, blood pressure, and cancer medications, among others. Other lasix-info.net include exempting raw materials from the value-added tax, and limiting future price hikes to over-the-counter drugs used for non-life threatening conditions. They also suggested increasing prices of some meds while reducing others to balance things out.
More from Enterprise
Banks threaten to look beyond London as windfall tax talk grows
International lenders say more tax could tip the balance as…
Granite is about to test whether Egypt’s funds still need administrators
The asset manager and blockchain builder Tarmiiz have entered the…
Gulf stock exchanges are growing in importance, but they’re still a long way from becoming capital market hubs -Fitch
The diagnosis lands in a year when UAE and Saudi…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…